- KR₩1tn
- KR₩1tn
- KR₩229bn
- 80
- 11
- 75
- 59
Annual income statement for Medy Tox, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 140,828 | 184,870 | 195,096 | 221,121 | 228,622 |
| Cost of Revenue | |||||
| Gross Profit | 74,341 | 105,853 | 126,405 | 133,871 | 139,029 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 182,279 | 54,520 | 154,250 | 196,864 | 209,801 |
| Operating Profit | -41,452 | 130,349 | 40,846 | 24,257 | 18,821 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -42,139 | 128,265 | 49,526 | 15,853 | 17,499 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -30,039 | 93,263 | 36,596 | 9,690 | 16,074 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -29,577 | 94,154 | 37,010 | 9,755 | 16,955 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -29,577 | 93,179 | 36,035 | 8,780 | 15,980 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -4,172 | 3,825 | 6,170 | 739 | 2,541 |
| Dividends per Share |